首页 > 最新文献

Frontiers in Ophthalmology最新文献

英文 中文
Oculometric biomarkers of visuomotor deficits in clinically asymptomatic patients with systemic lupus erythematosus undergoing long-term hydroxychloroquine treatment 长期接受羟氯喹治疗的临床无症状系统性红斑狼疮患者视觉运动障碍的眼部生物标志物
Pub Date : 2024-07-22 DOI: 10.3389/fopht.2024.1354892
Andrew R. Berneshawi, Kimia Seyedmadani, Rahul Goel, Mark R. Anderson, Terence L. Tyson, Yasmin M. Akay, Metin Akay, Loh-Shan B. Leung, Leland S. Stone
This study examines a set of oculomotor measurements, or “oculometric” biomarkers, as potential early indicators of visual and visuomotor deficits due to retinal toxicity in asymptomatic Systemic Lupus Erythematosus (SLE) patients on long-term hydroxychloroquine (HCQ) treatment. The aim is to identify subclinical functional impairments that are otherwise undetectable by standard clinical tests and to link them to structural retinal changes.We measured oculomotor responses in a cohort of SLE patients on chronic HCQ therapy using a previously established behavioral task and analysis technique. We also examined the relationship between oculometrics, OCT measures of retinal thickness, and standard clinical perimetry measures of visual function in our patient group using Bivariate Pearson Correlation and a Linear Mixed-Effects Model (LMM).Significant visual and visuomotor deficits were found in 12 asymptomatic SLE patients on long-term HCQ therapy compared to a cohort of 17 age-matched healthy controls. Notably, six oculometrics were significantly different. The median initial pursuit acceleration was 22%, steady-state pursuit gain 16%, proportion smooth 7%, and target speed responsiveness 31% lower, while catch-up saccade amplitude was 46% and fixation error 46% larger. Excluding the two patients with diagnosed mild toxicity, four oculometrics, all but fixation error and proportion smooth, remained significantly impaired compared to controls. Across our population of 12 patients (24 retinae), we found that pursuit latency, initial acceleration, steady-state gain, and fixation error were linearly related to retinal thickness even when age was accounted for, while standard measures of clinical function (Mean Deviation and Pattern Standard Deviation) were not.Our data show that specific oculometrics are sensitive early biomarkers of functional deficits in SLE patients on HCQ that could be harnessed to assist in the early detection of HCQ-induced retinal toxicity and other visual pathologies, potentially providing early diagnostic value beyond standard visual field and OCT evaluations.
本研究将一组眼球运动测量指标或 "眼球测量 "生物标志物作为无症状、长期接受羟氯喹(HCQ)治疗的系统性红斑狼疮(SLE)患者视网膜毒性引起的视觉和视觉运动障碍的潜在早期指标。我们使用以前建立的行为任务和分析技术,测量了一批长期接受 HCQ 治疗的系统性红斑狼疮患者的眼球运动反应。我们还使用双变量皮尔逊相关性和线性混合效应模型(LMM)研究了患者群体中的眼球测量、视网膜厚度的 OCT 测量和视觉功能的标准临床近视测量之间的关系。与 17 名年龄匹配的健康对照组相比,12 名长期接受 HCQ 治疗的无症状系统性红斑狼疮患者出现了明显的视觉和视觉运动障碍。值得注意的是,有六项视力测量指标存在显著差异。初始追视加速度中位数为22%,稳态追视增益中位数为16%,平滑比例中位数为7%,目标速度反应性中位数为31%,而追视囊泡振幅中位数为46%,固定误差中位数为46%。除去两名确诊为轻度中毒的患者,与对照组相比,除定点误差和平稳比例外,其他四项视力测量指标仍然存在明显缺陷。在我们的 12 名患者(24 个视网膜)中,我们发现追视延迟、初始加速度、稳态增益和固定误差与视网膜厚度呈线性关系,即使考虑到年龄因素也是如此,而临床功能的标准测量(平均偏差和模式标准偏差)则不然。我们的数据表明,特定的眼球测量法是服用HCQ的系统性红斑狼疮患者功能障碍的敏感早期生物标志物,可用于协助早期检测HCQ引起的视网膜毒性和其他视觉病变,其早期诊断价值可能超过标准视野和OCT评估。
{"title":"Oculometric biomarkers of visuomotor deficits in clinically asymptomatic patients with systemic lupus erythematosus undergoing long-term hydroxychloroquine treatment","authors":"Andrew R. Berneshawi, Kimia Seyedmadani, Rahul Goel, Mark R. Anderson, Terence L. Tyson, Yasmin M. Akay, Metin Akay, Loh-Shan B. Leung, Leland S. Stone","doi":"10.3389/fopht.2024.1354892","DOIUrl":"https://doi.org/10.3389/fopht.2024.1354892","url":null,"abstract":"This study examines a set of oculomotor measurements, or “oculometric” biomarkers, as potential early indicators of visual and visuomotor deficits due to retinal toxicity in asymptomatic Systemic Lupus Erythematosus (SLE) patients on long-term hydroxychloroquine (HCQ) treatment. The aim is to identify subclinical functional impairments that are otherwise undetectable by standard clinical tests and to link them to structural retinal changes.We measured oculomotor responses in a cohort of SLE patients on chronic HCQ therapy using a previously established behavioral task and analysis technique. We also examined the relationship between oculometrics, OCT measures of retinal thickness, and standard clinical perimetry measures of visual function in our patient group using Bivariate Pearson Correlation and a Linear Mixed-Effects Model (LMM).Significant visual and visuomotor deficits were found in 12 asymptomatic SLE patients on long-term HCQ therapy compared to a cohort of 17 age-matched healthy controls. Notably, six oculometrics were significantly different. The median initial pursuit acceleration was 22%, steady-state pursuit gain 16%, proportion smooth 7%, and target speed responsiveness 31% lower, while catch-up saccade amplitude was 46% and fixation error 46% larger. Excluding the two patients with diagnosed mild toxicity, four oculometrics, all but fixation error and proportion smooth, remained significantly impaired compared to controls. Across our population of 12 patients (24 retinae), we found that pursuit latency, initial acceleration, steady-state gain, and fixation error were linearly related to retinal thickness even when age was accounted for, while standard measures of clinical function (Mean Deviation and Pattern Standard Deviation) were not.Our data show that specific oculometrics are sensitive early biomarkers of functional deficits in SLE patients on HCQ that could be harnessed to assist in the early detection of HCQ-induced retinal toxicity and other visual pathologies, potentially providing early diagnostic value beyond standard visual field and OCT evaluations.","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":"13 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141816146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The significance of growth shells in development of symmetry, transparency, and refraction of the human lens 生长壳在人类晶状体的对称性、透明度和折射率发育过程中的意义
Pub Date : 2024-07-19 DOI: 10.3389/fopht.2024.1434327
Teri M. Greiling, JUDY M. Clark, John I. Clark
Human visual function depends on the biological lens, a biconvex optical element formed by coordinated, synchronous generation of growth shells produced from ordered cells at the lens equator, the distal edge of the epithelium. Growth shells are comprised of straight (St) and S-shaped (SSh) lens fibers organized in highly symmetric, sinusoidal pattern which optimizes both the refractile, transparent structure and the unique microcirculation that regulates hydration and nutrition over the lifetime of an individual. The fiber cells are characterized by diversity in composition and age. All fiber cells remain interconnected in their growth shells throughout the life of the adult lens. As an optical element, cellular differentiation is constrained by the physical properties of light and its special development accounts for its characteristic symmetry, gradient of refractive index (GRIN), short range transparent order (SRO), and functional longevity. The complex sinusoidal structure is the basis for the lens microcirculation required for the establishment and maintenance of image formation.
人类的视觉功能取决于生物晶状体,这是一种双凸透镜光学元件,由晶状体赤道部(上皮细胞的远端边缘)的有序细胞协调同步生成的生长壳形成。晶状体生长壳由直型(St)和 S 型(SSh)晶状体纤维组成,以高度对称的正弦模式组织,从而优化了折射透明结构和独特的微循环,在个体的一生中调节水合和营养。纤维细胞的组成和年龄具有多样性。在成人晶状体的整个生命周期中,所有纤维细胞在其生长外壳中保持相互连接。作为一种光学元件,细胞分化受到光的物理特性的限制,其特殊的发育过程造就了其特有的对称性、折射率梯度(GRIN)、短程透明阶(SRO)和功能寿命。复杂的正弦结构是晶状体微循环的基础,而晶状体微循环是建立和维持图像形成所必需的。
{"title":"The significance of growth shells in development of symmetry, transparency, and refraction of the human lens","authors":"Teri M. Greiling, JUDY M. Clark, John I. Clark","doi":"10.3389/fopht.2024.1434327","DOIUrl":"https://doi.org/10.3389/fopht.2024.1434327","url":null,"abstract":"Human visual function depends on the biological lens, a biconvex optical element formed by coordinated, synchronous generation of growth shells produced from ordered cells at the lens equator, the distal edge of the epithelium. Growth shells are comprised of straight (St) and S-shaped (SSh) lens fibers organized in highly symmetric, sinusoidal pattern which optimizes both the refractile, transparent structure and the unique microcirculation that regulates hydration and nutrition over the lifetime of an individual. The fiber cells are characterized by diversity in composition and age. All fiber cells remain interconnected in their growth shells throughout the life of the adult lens. As an optical element, cellular differentiation is constrained by the physical properties of light and its special development accounts for its characteristic symmetry, gradient of refractive index (GRIN), short range transparent order (SRO), and functional longevity. The complex sinusoidal structure is the basis for the lens microcirculation required for the establishment and maintenance of image formation.","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":"105 26","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141820654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Retinal metabolism in health and disease 社论:健康与疾病中的视网膜新陈代谢
Pub Date : 2024-07-17 DOI: 10.3389/fopht.2024.1459318
Sai Kocherlakota, James B. Hurley, Daisy Y. Shu
{"title":"Editorial: Retinal metabolism in health and disease","authors":"Sai Kocherlakota, James B. Hurley, Daisy Y. Shu","doi":"10.3389/fopht.2024.1459318","DOIUrl":"https://doi.org/10.3389/fopht.2024.1459318","url":null,"abstract":"","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":" 27","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141829990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computational single fundus image restoration techniques: a review 计算单眼眼底图像修复技术:综述
Pub Date : 2024-06-12 DOI: 10.3389/fopht.2024.1332197
Shuhe Zhang, Carroll A B Webers, T. Berendschot
Fundus cameras are widely used by ophthalmologists for monitoring and diagnosing retinal pathologies. Unfortunately, no optical system is perfect, and the visibility of retinal images can be greatly degraded due to the presence of problematic illumination, intraocular scattering, or blurriness caused by sudden movements. To improve image quality, different retinal image restoration/enhancement techniques have been developed, which play an important role in improving the performance of various clinical and computer-assisted applications. This paper gives a comprehensive review of these restoration/enhancement techniques, discusses their underlying mathematical models, and shows how they may be effectively applied in real-life practice to increase the visual quality of retinal images for potential clinical applications including diagnosis and retinal structure recognition. All three main topics of retinal image restoration/enhancement techniques, i.e., illumination correction, dehazing, and deblurring, are addressed. Finally, some considerations about challenges and the future scope of retinal image restoration/enhancement techniques will be discussed.
眼底照相机被眼科医生广泛用于监测和诊断视网膜病变。遗憾的是,没有一个光学系统是完美无缺的,由于存在照明问题、眼内散射或突然移动造成的模糊,视网膜图像的可视性可能会大大降低。为了提高图像质量,人们开发了不同的视网膜图像修复/增强技术,这些技术在提高各种临床和计算机辅助应用的性能方面发挥着重要作用。本文全面回顾了这些修复/增强技术,讨论了其基本数学模型,并展示了如何在现实生活中有效应用这些技术,以提高视网膜图像的视觉质量,从而实现潜在的临床应用,包括诊断和视网膜结构识别。视网膜图像复原/增强技术的所有三个主要课题,即光照校正、去毛刺和去模糊,均有涉及。最后,还将讨论视网膜图像复原/增强技术面临的挑战和未来发展方向。
{"title":"Computational single fundus image restoration techniques: a review","authors":"Shuhe Zhang, Carroll A B Webers, T. Berendschot","doi":"10.3389/fopht.2024.1332197","DOIUrl":"https://doi.org/10.3389/fopht.2024.1332197","url":null,"abstract":"Fundus cameras are widely used by ophthalmologists for monitoring and diagnosing retinal pathologies. Unfortunately, no optical system is perfect, and the visibility of retinal images can be greatly degraded due to the presence of problematic illumination, intraocular scattering, or blurriness caused by sudden movements. To improve image quality, different retinal image restoration/enhancement techniques have been developed, which play an important role in improving the performance of various clinical and computer-assisted applications. This paper gives a comprehensive review of these restoration/enhancement techniques, discusses their underlying mathematical models, and shows how they may be effectively applied in real-life practice to increase the visual quality of retinal images for potential clinical applications including diagnosis and retinal structure recognition. All three main topics of retinal image restoration/enhancement techniques, i.e., illumination correction, dehazing, and deblurring, are addressed. Finally, some considerations about challenges and the future scope of retinal image restoration/enhancement techniques will be discussed.","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":"117 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141352367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic review of ocular surface treatments in the setting of thyroid eye disease 甲状腺眼病患者眼表治疗的系统回顾
Pub Date : 2024-06-12 DOI: 10.3389/fopht.2024.1352355
Anthony Stephen Wong, James G. Chelnis
Approximately 85% of patients with thyroid eye disease experience ocular surface symptoms. Although corneal exposure plays a role in inducing inflammatory changes to the ocular surface, multiple studies reveal more complexity to the abnormal tear film composition and parameters in thyroid eye disease patients including those who do not have proptosis or increased corneal exposure. Currently, a majority of cases of thyroid associated dry eye symptoms are given treatments intended for ocular surface disease arising from different etiologies. Medline via Ovid, Cochrane CENTRAL, PubMed, and Google Scholar were systematically searched for articles evaluating the efficacy of treatments for dry eye symptoms in patients with thyroid eye disease. Articles were from all geographic regions and dates ranged from inception until October 2023. Seven papers ultimately met inclusion criteria and were included in this review. These papers revealed that multiple topical and non-topical treatment modalities address dry eye symptoms in thyroid eye disease and improve subjective and objective ocular surface parameters. However, due to the few studies that exist and due to disparities in sample size and study design, no overwhelming best practices were identified that could influence clinical practice.This systematic review identifies the current treatments that exist and highlights the clear unmet need for a large population suffering with dry eye symptoms. Ideally, further well-designed investigations into this area would target topical, non-invasive modalities to develop first line options for thyroid eye disease patients.
大约85%的甲状腺眼病患者会出现眼表症状。虽然角膜暴露在诱发眼表炎性变化方面起着一定的作用,但多项研究显示,甲状腺眼病患者(包括没有突眼或角膜暴露增加的患者)的泪膜成分和参数异常更为复杂。目前,大多数甲状腺相关干眼症病例都接受了针对不同病因引起的眼表疾病的治疗。我们通过 Ovid Medline、Cochrane CENTRAL、PubMed 和 Google Scholar 系统地检索了评估甲状腺眼病患者干眼症状治疗效果的文章。文章来自各个地区,日期从开始到 2023 年 10 月不等。最终有七篇论文符合纳入标准并被纳入本综述。这些论文显示,多种局部和非局部治疗方法可解决甲状腺眼病患者的干眼症状,并改善主观和客观眼表参数。然而,由于现有的研究较少,而且样本量和研究设计存在差异,因此没有发现可以影响临床实践的压倒性最佳实践。本系统综述确定了目前存在的治疗方法,并强调了大量干眼症患者的需求明显未得到满足。理想的情况是,对这一领域进行进一步精心设计的研究,以局部、非侵入性方式为目标,为甲状腺眼病患者开发一线治疗方案。
{"title":"Systematic review of ocular surface treatments in the setting of thyroid eye disease","authors":"Anthony Stephen Wong, James G. Chelnis","doi":"10.3389/fopht.2024.1352355","DOIUrl":"https://doi.org/10.3389/fopht.2024.1352355","url":null,"abstract":"Approximately 85% of patients with thyroid eye disease experience ocular surface symptoms. Although corneal exposure plays a role in inducing inflammatory changes to the ocular surface, multiple studies reveal more complexity to the abnormal tear film composition and parameters in thyroid eye disease patients including those who do not have proptosis or increased corneal exposure. Currently, a majority of cases of thyroid associated dry eye symptoms are given treatments intended for ocular surface disease arising from different etiologies. Medline via Ovid, Cochrane CENTRAL, PubMed, and Google Scholar were systematically searched for articles evaluating the efficacy of treatments for dry eye symptoms in patients with thyroid eye disease. Articles were from all geographic regions and dates ranged from inception until October 2023. Seven papers ultimately met inclusion criteria and were included in this review. These papers revealed that multiple topical and non-topical treatment modalities address dry eye symptoms in thyroid eye disease and improve subjective and objective ocular surface parameters. However, due to the few studies that exist and due to disparities in sample size and study design, no overwhelming best practices were identified that could influence clinical practice.This systematic review identifies the current treatments that exist and highlights the clear unmet need for a large population suffering with dry eye symptoms. Ideally, further well-designed investigations into this area would target topical, non-invasive modalities to develop first line options for thyroid eye disease patients.","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":"35 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141354377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing ectasia screening using advanced AS-OCT: a case series of challenging refractive candidates 利用先进的 AS-OCT 加强异位症筛查:具有挑战性的屈光候选者病例系列
Pub Date : 2024-06-11 DOI: 10.3389/fopht.2024.1405443
N. Mohr, Stefan Kassumeh, N. Luft, M. Dirisamer, Siegfried G. Priglinger, Wolfgang J. Mayer
Ectasia screening in candidates for laser refractive surgery is mandatory during preoperative evaluation. Despite the availability of modern imaging techniques, refractive surgeons often face borderline decisions when patients present with suspicious tomographic findings. This case series presents refractive candidates with suspicious tomographic findings and demonstrates how to interpret them using Scheimpflug imaging and additional anterior segment optical coherence tomography (AS-OCT).Department of Ophthalmology, University Hospital, LMU Munich.This case series examines six potential candidates for refractive surgery with a mean age of 29.2 ± 3.9 years, whose corneal assessments using Scheimpflug imaging raised suspicion for ectasia. Each candidate was additionally examined with AS-OCT and reevaluated. The mean manifest subjective spherical equivalent was -3.67 ± 1.8 diopters. The total corneal thickness measured 537 µm ± 30 µm at its thinnest point. None of the candidates had any reported underlying corneal or ophthalmic diseases, and slit lamp examinations revealed no abnormal morphological findings.Both Scheimpflug imaging and AS-OCT are appropriate tools for screening refractive candidates for ectasia. While topographic and elevation analyses yielded comparable results regarding corneal structure, the epithelial mapping provided by AS-OCT played a critical role in decision-making for cases with borderline tomographic findings. Establishing a global consensus on the use of epithelial mapping in ectasia screening is necessary.
在术前评估中,必须对激光屈光手术候选者进行外翻筛查。尽管有了现代成像技术,但当患者出现可疑的断层扫描结果时,屈光外科医生往往会面临难以抉择的境地。本系列病例介绍了有可疑断层扫描结果的屈光手术候选者,并演示了如何使用 Scheimpflug 成像和额外的前段光学相干断层扫描(AS-OCT)来解释这些结果。本系列病例研究了六名平均年龄为(29.2 ± 3.9)岁的潜在屈光手术候选者,他们使用 Scheimpflug 成像对角膜进行评估后怀疑存在角膜异位。每位候选者都接受了 AS-OCT 检查和复查。主观球面等效的平均值为-3.67 ± 1.8 屈光度。角膜最薄处的总厚度为 537 µm ± 30 µm。所有候选者均未报告有任何潜在的角膜或眼科疾病,裂隙灯检查也未发现异常形态。虽然地形图和高程分析在角膜结构方面得出的结果不相上下,但 AS-OCT 提供的上皮映射在对断层扫描结果有争议的病例进行决策时发挥了关键作用。有必要就异位症筛查中上皮映射的使用达成全球共识。
{"title":"Enhancing ectasia screening using advanced AS-OCT: a case series of challenging refractive candidates","authors":"N. Mohr, Stefan Kassumeh, N. Luft, M. Dirisamer, Siegfried G. Priglinger, Wolfgang J. Mayer","doi":"10.3389/fopht.2024.1405443","DOIUrl":"https://doi.org/10.3389/fopht.2024.1405443","url":null,"abstract":"Ectasia screening in candidates for laser refractive surgery is mandatory during preoperative evaluation. Despite the availability of modern imaging techniques, refractive surgeons often face borderline decisions when patients present with suspicious tomographic findings. This case series presents refractive candidates with suspicious tomographic findings and demonstrates how to interpret them using Scheimpflug imaging and additional anterior segment optical coherence tomography (AS-OCT).Department of Ophthalmology, University Hospital, LMU Munich.This case series examines six potential candidates for refractive surgery with a mean age of 29.2 ± 3.9 years, whose corneal assessments using Scheimpflug imaging raised suspicion for ectasia. Each candidate was additionally examined with AS-OCT and reevaluated. The mean manifest subjective spherical equivalent was -3.67 ± 1.8 diopters. The total corneal thickness measured 537 µm ± 30 µm at its thinnest point. None of the candidates had any reported underlying corneal or ophthalmic diseases, and slit lamp examinations revealed no abnormal morphological findings.Both Scheimpflug imaging and AS-OCT are appropriate tools for screening refractive candidates for ectasia. While topographic and elevation analyses yielded comparable results regarding corneal structure, the epithelial mapping provided by AS-OCT played a critical role in decision-making for cases with borderline tomographic findings. Establishing a global consensus on the use of epithelial mapping in ectasia screening is necessary.","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":"92 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141359828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the strengths and limitations of multimodal ChatGPT-4 in detecting glaucoma using fundus images 评估多模式 ChatGPT-4 在利用眼底图像检测青光眼方面的优势和局限性
Pub Date : 2024-06-07 DOI: 10.3389/fopht.2024.1387190
S. A. Alryalat, Ayman Musleh, M. Kahook
This study evaluates the diagnostic accuracy of a multimodal large language model (LLM), ChatGPT-4, in recognizing glaucoma using color fundus photographs (CFPs) with a benchmark dataset and without prior training or fine tuning.The publicly accessible Retinal Fundus Glaucoma Challenge “REFUGE” dataset was utilized for analyses. The input data consisted of the entire 400 image testing set. The task involved classifying fundus images into either ‘Likely Glaucomatous’ or ‘Likely Non-Glaucomatous’. We constructed a confusion matrix to visualize the results of predictions from ChatGPT-4, focusing on accuracy of binary classifications (glaucoma vs non-glaucoma).ChatGPT-4 demonstrated an accuracy of 90% with a 95% confidence interval (CI) of 87.06%-92.94%. The sensitivity was found to be 50% (95% CI: 34.51%-65.49%), while the specificity was 94.44% (95% CI: 92.08%-96.81%). The precision was recorded at 50% (95% CI: 34.51%-65.49%), and the F1 Score was 0.50.ChatGPT-4 achieved relatively high diagnostic accuracy without prior fine tuning on CFPs. Considering the scarcity of data in specialized medical fields, including ophthalmology, the use of advanced AI techniques, such as LLMs, might require less data for training compared to other forms of AI with potential savings in time and financial resources. It may also pave the way for the development of innovative tools to support specialized medical care, particularly those dependent on multimodal data for diagnosis and follow-up, irrespective of resource constraints.
本研究评估了多模态大语言模型(LLM)ChatGPT-4在使用基准数据集和彩色眼底照片(CFP)识别青光眼方面的诊断准确性,无需事先训练或微调。输入数据包括整个 400 张图像测试集。任务包括将眼底图像分类为 "可能为青光眼 "或 "可能为非青光眼"。我们构建了一个混淆矩阵来直观显示 ChatGPT-4 的预测结果,重点关注二元分类(青光眼与非青光眼)的准确性。ChatGPT-4 的准确率为 90%,95% 置信区间(CI)为 87.06%-92.94%。灵敏度为 50%(95% CI:34.51%-65.49%),特异度为 94.44%(95% CI:92.08%-96.81%)。ChatGPT-4 无需事先对 CFP 进行微调就能达到相对较高的诊断准确性。考虑到包括眼科在内的专业医疗领域数据稀缺,与其他形式的人工智能相比,使用 LLM 等先进的人工智能技术可能需要更少的数据进行训练,从而节省时间和财政资源。它还可能为开发创新工具铺平道路,以支持专业医疗护理,特别是那些依赖多模态数据进行诊断和随访的医疗护理,而不受资源限制。
{"title":"Evaluating the strengths and limitations of multimodal ChatGPT-4 in detecting glaucoma using fundus images","authors":"S. A. Alryalat, Ayman Musleh, M. Kahook","doi":"10.3389/fopht.2024.1387190","DOIUrl":"https://doi.org/10.3389/fopht.2024.1387190","url":null,"abstract":"This study evaluates the diagnostic accuracy of a multimodal large language model (LLM), ChatGPT-4, in recognizing glaucoma using color fundus photographs (CFPs) with a benchmark dataset and without prior training or fine tuning.The publicly accessible Retinal Fundus Glaucoma Challenge “REFUGE” dataset was utilized for analyses. The input data consisted of the entire 400 image testing set. The task involved classifying fundus images into either ‘Likely Glaucomatous’ or ‘Likely Non-Glaucomatous’. We constructed a confusion matrix to visualize the results of predictions from ChatGPT-4, focusing on accuracy of binary classifications (glaucoma vs non-glaucoma).ChatGPT-4 demonstrated an accuracy of 90% with a 95% confidence interval (CI) of 87.06%-92.94%. The sensitivity was found to be 50% (95% CI: 34.51%-65.49%), while the specificity was 94.44% (95% CI: 92.08%-96.81%). The precision was recorded at 50% (95% CI: 34.51%-65.49%), and the F1 Score was 0.50.ChatGPT-4 achieved relatively high diagnostic accuracy without prior fine tuning on CFPs. Considering the scarcity of data in specialized medical fields, including ophthalmology, the use of advanced AI techniques, such as LLMs, might require less data for training compared to other forms of AI with potential savings in time and financial resources. It may also pave the way for the development of innovative tools to support specialized medical care, particularly those dependent on multimodal data for diagnosis and follow-up, irrespective of resource constraints.","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":" 19","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141373246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interleukin-1β activates matrix metalloproteinase-2 to alter lacrimal gland myoepithelial cell structure and function 白细胞介素-1β激活基质金属蛋白酶-2,改变泪腺肌上皮细胞的结构和功能
Pub Date : 2024-06-06 DOI: 10.3389/fopht.2024.1415002
Junji Morokuma, Ángela Gárriz, Danny Toribio, Sarah Pagni, D. Zoukhri
The aim of the present study is to investigate the role of c-Jun N-terminal kinase (JNK) and matrix metalloproteinase-2 (MMP-2) in mediating the effects of interleukin-1β (IL-1β) on the function of lacrimal gland myoepithelial cells (MECs). MECs isolated from an α-smooth muscle actin–green fluorescent protein (SMA-GFP) transgenic mouse were treated with IL-1β alone or in the presence of SP600125, a JNK inhibitor, or ARP100, an MMP-2 inhibitor. The GFP intensity and the cell size/area were measured, and on day 7, the SMA, calponin, and pro-MMP-2 protein levels and the MEC contraction were assessed. At baseline, the control and treated cells showed no differences in GFP intensity or cell size. Starting on day 2 and continuing on days 4 and 7, the GFP intensity and cell size were significantly lower in the IL-1β-treated samples, and these effects were alleviated following inhibition of either JNK or MMP-2. Compared with the control, the levels of SMA and calponin were lower in the IL-1β-treated samples, and both the JNK and MMP-2 inhibitors reversed this trend. The pro-MMP-2 protein level was elevated in the IL-1β-treated samples, and this effect was abolished by the JNK inhibitor. Finally, oxytocin-induced MEC contraction was diminished in the IL-1β-treated samples, and both the JNK and MMP-2 inhibitors reversed this effect. Our data suggest that IL-1β uses the JNK/MMP-2 pathways to alter MEC functions, which might account for the diminished tears associated with aqueous-deficient dry eye disease.
本研究旨在探讨c-Jun N-末端激酶(JNK)和基质金属蛋白酶-2(MMP-2)在介导白细胞介素-1β(IL-1β)影响泪腺肌上皮细胞(MECs)功能中的作用。从α-平滑肌肌动蛋白-绿色荧光蛋白(SMA-GFP)转基因小鼠体内分离出的泪腺肌上皮细胞单独或在JNK抑制剂SP600125或MMP-2抑制剂ARP100作用下接受IL-1β处理。测量 GFP 强度和细胞大小/面积,并在第 7 天评估 SMA、钙蛋白、促 MMP-2 蛋白水平和 MEC 收缩情况。基线时,对照组和处理过的细胞在 GFP 强度和细胞大小上没有差异。从第 2 天开始,持续到第 4 天和第 7 天,IL-1β 处理过的样本的 GFP 强度和细胞大小明显降低,抑制 JNK 或 MMP-2 后,这些影响得到缓解。与对照组相比,IL-1β处理的样本中SMA和钙蛋白水平较低,而JNK和MMP-2抑制剂都逆转了这一趋势。IL-1β处理的样本中促MMP-2蛋白水平升高,JNK抑制剂可消除这种影响。最后,催产素诱导的 MEC 收缩在 IL-1β 处理的样本中减弱,JNK 和 MMP-2 抑制剂都逆转了这种效应。我们的数据表明,IL-1β利用JNK/MMP-2途径改变了MEC的功能,这可能是水缺乏性干眼病导致泪液减少的原因。
{"title":"Interleukin-1β activates matrix metalloproteinase-2 to alter lacrimal gland myoepithelial cell structure and function","authors":"Junji Morokuma, Ángela Gárriz, Danny Toribio, Sarah Pagni, D. Zoukhri","doi":"10.3389/fopht.2024.1415002","DOIUrl":"https://doi.org/10.3389/fopht.2024.1415002","url":null,"abstract":"The aim of the present study is to investigate the role of c-Jun N-terminal kinase (JNK) and matrix metalloproteinase-2 (MMP-2) in mediating the effects of interleukin-1β (IL-1β) on the function of lacrimal gland myoepithelial cells (MECs). MECs isolated from an α-smooth muscle actin–green fluorescent protein (SMA-GFP) transgenic mouse were treated with IL-1β alone or in the presence of SP600125, a JNK inhibitor, or ARP100, an MMP-2 inhibitor. The GFP intensity and the cell size/area were measured, and on day 7, the SMA, calponin, and pro-MMP-2 protein levels and the MEC contraction were assessed. At baseline, the control and treated cells showed no differences in GFP intensity or cell size. Starting on day 2 and continuing on days 4 and 7, the GFP intensity and cell size were significantly lower in the IL-1β-treated samples, and these effects were alleviated following inhibition of either JNK or MMP-2. Compared with the control, the levels of SMA and calponin were lower in the IL-1β-treated samples, and both the JNK and MMP-2 inhibitors reversed this trend. The pro-MMP-2 protein level was elevated in the IL-1β-treated samples, and this effect was abolished by the JNK inhibitor. Finally, oxytocin-induced MEC contraction was diminished in the IL-1β-treated samples, and both the JNK and MMP-2 inhibitors reversed this effect. Our data suggest that IL-1β uses the JNK/MMP-2 pathways to alter MEC functions, which might account for the diminished tears associated with aqueous-deficient dry eye disease.","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":"96 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141378194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease 经皮三苯氧胺注射治疗甲状腺眼病的上眼睑回缩
Pub Date : 2024-05-17 DOI: 10.3389/fopht.2024.1388197
Shaun R. Parsons, Ario Wilson-Pogmore, Timothy J. Sullivan
To evaluate percutaneous triamcinolone (TA) injection efficacy in treating upper eyelid retraction (UER) for Australian thyroid eye disease (TED) patients.We conducted a retrospective analysis across 8 years and multiple diverse Australian centres identified UER patients who received TA injections. A single operator administered 40mg/1ml TA through upper eyelid skin. Assessments at 4-6 weeks and subsequent eyelid measurements gauged treatment response and complications.24 patients and 25 eyelids were included in the study. 91.6% were female, mean age 40.8 ± 10.3 years with mean follow-up of 17.5 months (± 18.5). Pre-treatment MRD1 was 6.2mm ± 1.4, and we observed a mean improvement of 2.2mm from pre-treatment to post-treatment (p<0.001). The mean UER measurement before treatment (defined as MRD1 - 4.0mm) was 3.0mm ± 1.3 (range, 0-6mm). After treatment, the mean UER measurement was -0.1mm. Quality of life (QOL) assessment improved significantly, from pre-treatment score of 4.13 ± 2.4 to post-treatment 8.0 ±1.7 (p<0.001).Percutaneous injection of TA is an effective and safe treatment option for UER in patients with TED. This technique can be performed without upper eyelid eversion, which makes it more tolerable for patients and less complex for the operator compared to the transconjunctival injection approach. Our results show a significant improvement in MRD1 and UER, as well as patient QOL. Moreover, we found a low rate of complications (4.2% induced ptosis) and no cases of raised intraocular pressure. Percutaneous TA injection can greatly reduce the need for eyelid lowering surgery in this patient population.
目的:评估经皮曲安西龙(TA)注射液治疗澳大利亚甲状腺眼病(TED)患者上眼睑回缩(UER)的疗效。由一名操作者通过上眼睑皮肤注射40毫克/1毫升TA。研究共纳入了 24 名患者和 25 个眼睑。91.6%的患者为女性,平均年龄(40.8 ± 10.3)岁,平均随访时间为 17.5 个月(± 18.5)个月。治疗前的 MRD1 为 6.2mm ± 1.4,我们观察到从治疗前到治疗后平均改善了 2.2mm(P<0.001)。治疗前的平均 UER 测量值(定义为 MRD1 - 4.0mm)为 3.0mm ± 1.3(范围为 0-6mm)。治疗后,UER的平均测量值为-0.1毫米。生活质量(QOL)评估从治疗前的 4.13 ± 2.4 分显著提高到治疗后的 8.0 ± 1.7 分(P<0.001)。经皮注射TA是治疗TED患者UER的一种有效、安全的方法。这种技术无需上眼睑外翻,因此与经结膜注射法相比,患者更容易耐受,操作也更简单。我们的研究结果表明,MRD1 和 UER 以及患者的 QOL 均有明显改善。此外,我们还发现并发症发生率很低(4.2% 诱发上睑下垂),没有眼压升高的病例。经皮 TA 注射可以大大减少这类患者对降低眼睑手术的需求。
{"title":"Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease","authors":"Shaun R. Parsons, Ario Wilson-Pogmore, Timothy J. Sullivan","doi":"10.3389/fopht.2024.1388197","DOIUrl":"https://doi.org/10.3389/fopht.2024.1388197","url":null,"abstract":"To evaluate percutaneous triamcinolone (TA) injection efficacy in treating upper eyelid retraction (UER) for Australian thyroid eye disease (TED) patients.We conducted a retrospective analysis across 8 years and multiple diverse Australian centres identified UER patients who received TA injections. A single operator administered 40mg/1ml TA through upper eyelid skin. Assessments at 4-6 weeks and subsequent eyelid measurements gauged treatment response and complications.24 patients and 25 eyelids were included in the study. 91.6% were female, mean age 40.8 ± 10.3 years with mean follow-up of 17.5 months (± 18.5). Pre-treatment MRD1 was 6.2mm ± 1.4, and we observed a mean improvement of 2.2mm from pre-treatment to post-treatment (p<0.001). The mean UER measurement before treatment (defined as MRD1 - 4.0mm) was 3.0mm ± 1.3 (range, 0-6mm). After treatment, the mean UER measurement was -0.1mm. Quality of life (QOL) assessment improved significantly, from pre-treatment score of 4.13 ± 2.4 to post-treatment 8.0 ±1.7 (p<0.001).Percutaneous injection of TA is an effective and safe treatment option for UER in patients with TED. This technique can be performed without upper eyelid eversion, which makes it more tolerable for patients and less complex for the operator compared to the transconjunctival injection approach. Our results show a significant improvement in MRD1 and UER, as well as patient QOL. Moreover, we found a low rate of complications (4.2% induced ptosis) and no cases of raised intraocular pressure. Percutaneous TA injection can greatly reduce the need for eyelid lowering surgery in this patient population.","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":"113 48","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141126480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal study of microphthalmia in connexin 50 knockout mice using spectral-domain optical coherence tomography 利用光谱域光学相干断层扫描技术对连接蛋白 50 基因敲除小鼠的小眼症进行纵向研究
Pub Date : 2024-05-03 DOI: 10.3389/fopht.2024.1387961
Taishi Painter, Chenxi Ou, X. Gong, Chun-hong Xia
Connexin 50 (Cx50) mediated signaling is essential for controlling the lens growth and size. Cx50 mutations cause microphthalmia, smaller lenses, and cataracts in humans and animals. These ocular defects have never been investigated in live Cx50 mutant mice by using non-invasive imaging techniques. Here, we report a longitudinal study of the ocular defects in Cx50 knockout (Cx50KO) mice from the ages of 3 weeks to 12 months by using spectral-domain optical coherence tomography (SD-OCT). The anterior chamber depth (ACD), lens thickness (LT), vitreous chamber depth (VCD), and axial length (AL) were measured along the visual axis and adjusted with corresponding refractive indices. The SD-OCT image data confirm age-related reductions of LT and AL in live Cx50KO mice compared to age-matched wild-type (WT) controls, and the reduction values are comparable to the in vitro measurements of Cx50KO eyeballs and lenses reported previously. Moreover, reductions of ACD were observed in Cx50KO mice at all ages studied while VCD changes are statistically insignificant in comparison to the WT controls. Therefore, Cx50KO’s microphthalmia with small lens is selectively associated with delayed ACD development but not the vitreous formation. This work supports the notion that lens size and/or growth is important for anterior chamber development.
由连接蛋白 50(Cx50)介导的信号传导对于控制晶状体的生长和大小至关重要。Cx50 突变会导致人类和动物出现小眼症、晶状体变小和白内障。这些眼部缺陷从未在活体 Cx50 突变小鼠中使用非侵入性成像技术进行过研究。在此,我们报告了利用光谱域光学相干断层扫描(SD-OCT)对 Cx50 基因敲除(Cx50KO)小鼠从 3 周龄到 12 个月龄的眼部缺陷进行的纵向研究。沿视轴测量了小鼠的前房深度(ACD)、晶状体厚度(LT)、玻璃体腔深度(VCD)和轴向长度(AL),并用相应的屈光指数进行了调整。与年龄匹配的野生型(WT)对照组相比,SD-OCT 图像数据证实了活体 Cx50KO 小鼠的 LT 和 AL 与年龄相关的减少,其减少值与之前报道的 Cx50KO 眼球和晶状体的体外测量值相当。此外,在所有研究年龄段的 Cx50KO 小鼠中都观察到了 ACD 的减少,而 VCD 的变化与 WT 对照组相比在统计学上并不显著。因此,Cx50KO小眼症与小晶状体选择性地与ACD发育延迟有关,而与玻璃体形成无关。这项研究支持晶状体大小和/或生长对前房发育很重要的观点。
{"title":"Longitudinal study of microphthalmia in connexin 50 knockout mice using spectral-domain optical coherence tomography","authors":"Taishi Painter, Chenxi Ou, X. Gong, Chun-hong Xia","doi":"10.3389/fopht.2024.1387961","DOIUrl":"https://doi.org/10.3389/fopht.2024.1387961","url":null,"abstract":"Connexin 50 (Cx50) mediated signaling is essential for controlling the lens growth and size. Cx50 mutations cause microphthalmia, smaller lenses, and cataracts in humans and animals. These ocular defects have never been investigated in live Cx50 mutant mice by using non-invasive imaging techniques. Here, we report a longitudinal study of the ocular defects in Cx50 knockout (Cx50KO) mice from the ages of 3 weeks to 12 months by using spectral-domain optical coherence tomography (SD-OCT). The anterior chamber depth (ACD), lens thickness (LT), vitreous chamber depth (VCD), and axial length (AL) were measured along the visual axis and adjusted with corresponding refractive indices. The SD-OCT image data confirm age-related reductions of LT and AL in live Cx50KO mice compared to age-matched wild-type (WT) controls, and the reduction values are comparable to the in vitro measurements of Cx50KO eyeballs and lenses reported previously. Moreover, reductions of ACD were observed in Cx50KO mice at all ages studied while VCD changes are statistically insignificant in comparison to the WT controls. Therefore, Cx50KO’s microphthalmia with small lens is selectively associated with delayed ACD development but not the vitreous formation. This work supports the notion that lens size and/or growth is important for anterior chamber development.","PeriodicalId":510339,"journal":{"name":"Frontiers in Ophthalmology","volume":" 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141129800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1